These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 3698167

  • 1. Pharmacokinetic study in a phase I trial with an alkylating agent, diacetyldianhydrogalactitol (DADAG).
    Erdélyi-Tóth V, Kerpel-Fronius S, Kanyár B, Eckhardt S.
    Cancer Chemother Pharmacol; 1986; 16(3):257-63. PubMed ID: 3698167
    [Abstract] [Full Text] [Related]

  • 2. Relation between dose, plasma concentration and toxicity in a phase I trial using high dose intermittent administration of an alkylating agent, diacetyldianhydrogalactitol (DADAG).
    Kerpel-Fronius S, Erdélyi-Tóth V, Gyergyay F, Hindy I, Mechl Z, Nekulová M, Somfai-Relle S, Kovács P, Ujj G, Kanyár B.
    Cancer Chemother Pharmacol; 1986; 16(3):264-8. PubMed ID: 3698168
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics and metabolism of dianhydrogalactitol DAG in patients: a comparison with the human disposition of dibromodulcitol DBD.
    Horváth IP, Csetényi J, Kerpel-Fronius S, Hegedüs L, Kanyár B, Eckhardt S.
    Eur J Cancer Clin Oncol; 1986 Feb; 22(2):163-71. PubMed ID: 3699079
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical and pharmacologic evaluation of split-dose intermittent therapy with dianhydrogalactitol.
    Eagan RT, Ames MM, Powis G, Kovach JS.
    Cancer Treat Rep; 1982 Feb; 66(2):283-7. PubMed ID: 7034934
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Interaction of GGCC sequences of DNA with anticancer dianhydrogalacticol, detected by inhibition of restriction enzyme BspI.
    Financsek I, Guczi J, Hidvégi EJ.
    Acta Biochim Biophys Acad Sci Hung; 1984 Feb; 19(3-4):177-84. PubMed ID: 6100663
    [Abstract] [Full Text] [Related]

  • 10. In vivo study on alkylation site in DNA by the bifunctional dianhydrogalactitol.
    Institoris E.
    Chem Biol Interact; 1981 May; 35(2):207-16. PubMed ID: 7214602
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Caspases promoted DADAG-induced apoptosis in human leukemia HL-60 cells.
    Yang JN, Liu CX, Xu H, Pan QC.
    Acta Pharmacol Sin; 2002 May; 23(5):461-6. PubMed ID: 11978198
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dianhydrogalactitol (NSC-132313): pharmacokinetics in normal and tumor-bearing rat brain and antitumor activity against three intracerebral rodent tumors.
    Levin VA, Freeman-Dove MA, Maroten CE.
    J Natl Cancer Inst; 1976 Mar; 56(3):535-9. PubMed ID: 1255783
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.